Classification of Medicines
Pursuant to section 106(1) of the Medicines Act 1981, I, Chris James, Group Manager, Medsafe, Ministry of Health, acting under delegated authority, hereby declare the following:
Every reference to a medicine in this notice applies whether the medicine is synthetic in origin or is from biological or mineral sources.
Unless specific reference is made otherwise, every reference applies also to medicines that are:
Unless specific reference is made otherwise, every reference to a medicine applies:
Where any reference is modified by a statement of the strength of the medicine, the strength is calculated using the free acid, base, alcohol or element unless specifically stated otherwise.
In accordance with section 106(2) of the Act, to the extent that any part of this notice is inconsistent with any provisions of any regulations made under section 105(1)(j) of the Act, the provisions in those regulations cease to have effect while this notice remains in force.
Measles vaccine; except when administered in combination with mumps and rubella vaccines in a combination product the supply of which the Minister of Health has given consent, by a vaccinator who has successfully completed a training course approved by the Ministry of Health and who complies with the immunisation standards of the Ministry of Health
Mumps vaccine; except when administered in combination with measles and rubella vaccines in a combination product the supply of which the Minister of Health has given consent, by a vaccinator who has successfully completed a training course approved by the Ministry of Health and who complies with the immunisation standards of the Ministry of Health
Rubella vaccine; except when administered in combination with mumps and measles vaccines in a combination product the supply of which the Minister of Health has given consent, a vaccinator who has successfully completed a training course approved by the Ministry of Health and who complies with the immunisation standards of the Ministry of Health
Dated this 1st day of October 2020.
CLARE PERRY, Acting Deputy Director-General, Health System Improvement and Innovation, Ministry of Health.